AbbVie Inc.

ABBV | NYSE

Price Alert Chart Builder DCF Calculator

$264.53

+$0.57 (+0.22%)

At close: Sep 21, 2026, 3:59 PM ET

$263.70

-$0.83 (-0.31%)

Pre-market: Sep 22, 2026, 9:18 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $467.37B

Enterprise Value $531.62B

Beta 0.28

Average Volume 6.26M

Shares Outstanding (Diluted) 1.77B

Shares Change YoY -0.06%

Institutional Ownership 73.39%

Exchange NYSE

ISIN US00287Y1091

Price Performance

Price Change 1M -0.2%

Price Change 3M 12.7%

Price Change 6M 27.7%

Price Change YTD 15.4%

Price Change 1Y 18.8%

Price Change 3Y 73.2%

Price Change 5Y 147.1%

1M CAGR (ann.) 7.5%

1Y CAGR (ann.) 22.9%

5Y CAGR (ann.) 24.2%

All-Time CAGR 20.4%

Valuation

PE Ratio 74.52

Forward PE 16.26

PEG Ratio 1.09

Forward PEG 4.52

PS Ratio 7.26

Forward PS 6.40

PB Ratio -78.75

P/FCF Ratio 23.75

P/Adj. FCF Ratio 24.99

P/OCF Ratio 24.03

EV/Sales 8.26

EV/EBIT 39.93

EV/EBITDA 25.03

EV/FCF 27.01

Earnings Yield 1.3%

FCF Yield 4.2%

Adj. FCF Yield 4.0%

Financial Health

Net Debt $64.25B

Total Debt $70.82B

Cash & Short-Term Investments $6.57B

Total Assets $135.13B

Current Ratio 0.81

Quick Ratio 0.69

Debt / Equity Ratio -11.93

Debt / EBITDA 3.34

Debt / FCF 3.60

OCF / Debt 0.28

Interest Coverage 6.47

Altman Z-Score 2.54

Piotroski F-Score 8

Margins & Profitability

Gross Profit Margin 71.5%

Operating Profit Margin 29.3%

EBITDA Margin 33.0%

Net Profit Margin 9.8%

FCF Margin 30.6%

Adj. FCF Margin 29.1%

SBC / Revenue 1.5%

SBC Impact (per share) -5.0%

Returns

Return on Assets 4.7%

Return on Equity -136.5%

Return on Invested Capital 13.5%

Return on Capital Employed 20.2%

Return on Tangible Assets 12.5%

Historical Growth (CAGR)

Revenue CAGR 3Y 4.8%

Revenue CAGR 5Y 3.7%

Revenue CAGR 10Y 10.0%

EPS CAGR 3Y -10.1%

EPS CAGR 5Y -0.9%

EPS CAGR 10Y 0.2%

FCF CAGR 3Y -7.4%

FCF CAGR 5Y 0.1%

FCF CAGR 10Y 9.9%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 43

EPS Growth Next 3Y 77.3%

Revenue Growth Next 3Y 8.9%

Earnings Date Oct 29, 2026

EPS Estimate (next Q) $3.86

EPS Growth Est (next Q) 107.5%

Revenue Est (next Q) $17.31B

Revenue Growth Est (next Q) 9.7%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value $17.75

Lynch Upside -93.3%

Price Target $287.08

Price Target Upside 8.5%

Cash Flow

Operating Cash Flow $19.51B

Free Cash Flow $19.68B

Adj. Free Cash Flow $18.71B

FCF Per Share $11.11

OCF Per Share $11.01

OCF/S Ratio 30.3%

Income Statement

Revenue $64.39B

Gross Profit $46.02B

Operating Income $18.88B

EBITDA $21.24B

Net Income $6.31B

EPS (Diluted) $3.55

Revenue / Employee $1.13M

Profit / Employee $110.77K

Employees 57,000

Dividends

Annual Dividend $6.83

Dividend Yield 2.58%

Payout Ratio 192.4%

FCF Payout Ratio 60.9%

Adj. FCF Payout Ratio 64.0%

Dividend Growth (YoY) 5.6%

Pay Frequency Quarterly

Ex-Dividend Date Oct 14, 2026